Company intelligence / Profile preview

Bliss GVS Pharma

Mumbai, Maharashtra, Indiablissgvs.com ↗

Ownership: Private
Employees: ~750
Development stage: Other

Overview

Bliss GVS Pharma has a robust commercial portfolio with over 250 products marketed globally. The company leads in suppositories and pessaries and holds one of the largest anti-malarial portfolios worldwide. Its flagship anti-malarial brands such as Lonart and P-Alaxin are widely used in Africa. The company also offers OTC and herbal products under brands like GREENTOL and FRICKS lozenges. Products are manufactured at EU-GMP/WHO-GMP certified facilities.

Therapeutic areas: HematologyRheumatologyInfectious DiseasesOther
Modalities: Small moleculeHerbal product
Industry: Biotech

Partnerships

Major supply contracts with African governments/agencies for anti-malarialscontract manufacturing for global pharma companies—specific partners undisclosed due to confidentiality agreements

Beyond the preview

Go deeper on Bliss GVS Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bliss GVS Pharma.

Explore the full profile